Business Standard
Home / India News / Sun Pharma Advanced Research Company gets FIPB approval

Sun Pharma Advanced Research Company gets FIPB approval

Image

Capital Market
Last Updated : Oct 30 2015 | 12:11 AM IST

For proposed rights issue

Sun Pharma Advanced Research Company announced that it has received the FIPB approval for an aggregate amount of Rs 250 crore in the proposed rights issue.

Powered by Capital Market - Live News

Also Read

Sun Pharma Advanced Research Company gets Complete Response letter from USFDA

Sun Pharma Advanced Research Company gets Complete Response letter from USFDA

Sun Pharma Advanced Research Company receives Complete Response Letter for Levetiracetam NDA

Sun Pharma Advanced Research Company receives Complete Response Letter for Levetiracetam NDA

Sun Pharma Advanced Research Company reports standalone net loss of Rs 1.65 crore in the June 2015 quarter

Sun Pharma Advanced Research Company reports standalone net loss of Rs 1.65 crore in the June 2015 quarter

Board of Sun Pharma Advanced Research Company approves rights issue

Board of Sun Pharma Advanced Research Company approves rights issue

Sun Pharma Advanced Research Company to hold board meeting

Sun Pharma Advanced Research Company to hold board meeting

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 29 2015 | 5:37 PM IST

Explore News

Market LIVEMarket TodaySai Life Sciences IPOToss The Coin IPO AllotmentLatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon